Bronchoalveolar lavage (BAL) studies are useful
to assess the lower respiratory tract inflammation and to
study the pathogenesis of various lung diseases (1). Even
though potent chemotherapeutic regimens are available
currently to treat patients with pulmonary tuberculosis,
radiographic and pulmonary function abnormalities persist
in a proportion of tuberculosis patients despite treatment
(2). Evaluation of lung immune process in pulmonary
tuberculosis using BAL may aid in understanding
the mechanism of lung injury and fibrosis which, in turn,
may help to formulate modalities of treatment that prevent
fibrosis. In addition, since BAL samples the epithelial
lining fluid of the alveoli, it is possible that it may aid
in early diagnosis of sputum smear negative pulmonary
tuberculosis